Purdue Pharma, Pills, and Pot: The Need for Insurers to Have a Plan

Pessin Katz Law, P.A.

Pessin Katz Law, P.A.

Every day in the United States, 130 people die from opioid overdoses.[1] To date, the opioid epidemic, as it has been termed, has claimed the lives of more than 420,000 people[2] and affected the lives of many more.[3] Because the drugs involved—codeine, oxycodone, and fentanyl, among others—are physically addictive,[4] anyone can become dependent and everyone is at risk.[5] The epidemic is even affecting our nation’s newborns, with neonatal abstinence syndrome increasing five-fold between 2004 and 2014.[6]

While the human cost of the opioid epidemic is undeniably tragic, its impact is felt economically as well. The National Institutes of Health’s National Institute on Drug Abuse estimates costs associated with overdoses, medical care, addiction treatment, lost productivity, criminal justice expenditures, and family support services at $78.5 billion per year.[7] Aligned with that figure, the non-profit health research and consulting organization Altarum has projected opioid-related costs, in the aggregate, to reach $1.5 trillion by 2020.[8]

Driving the epidemic, at least in part, is the fact that, beginning the 1990s, a number of the “big pharma” opioid manufacturers mounted marketing campaigns designed to persuade doctors to proscribe opioids for chronic, non-cancer pain.[9] These campaigns suggested that opioids were safe and that the risk of patient addiction could be mitigated.[10] The arguable falsity of those claims is now at the center of the massive multi-district litigation (“MDL”) assigned to Judge Dan Polster of the U.S. District Court for the Northern District of Ohio.[11]

At present, the MDL includes more than 2,300 individual cases brought by states, local governments, Native American tribes, and others.[12] The defendants include manufacturers responsible for allegedly deceptive marketing campaigns and distributors who allegedly failed to prevent the diversion of opioids to illegal markets.[13] And there are more than 300 other suits that have not been consolidated into the MDL, including several suits for increases in health insurance costs caused by the epidemic.[14]

The scope of this litigation and, perhaps more important, its most conspicuous results thus far—the bankruptcy of two defendants, Purdue Pharma (Purdue Frederick Company, Purdue Pharma Inc., and Purdue Pharma L.P.) and Insys (Insys Manufacturing LLC, Insys Pharma, Inc., and Insys Therapeutics, Inc.)[15]—should give insurers pause. How, in light of these developments, are insurers to conduct business in the midst of the ongoing crisis and its fallout? Because if the history of asbestos claims is any indicator,[16] the MDL is unlikely to bring an end to litigation, and the consequences for insurers, insureds, and other interested parties may last decades.

Consider, first, the implications of various defendants filing for Chapter 11. Where there are bankruptcies, there are bankruptcy plans and, for these corporations, almost certainly releases. Although it is, as yet, unclear who will be released from what future claims, there is sure to be a search for further defendants. Who will be next, and what policies do they hold? Other manufacturers and distributors? Corporate officers? The doctors running “pill mills”? Healthcare facilities? Employers by way of workers’ compensation claims?

Relatedly, consider the challenges of subrogation in light of these bankruptcies. How might insurance companies go about establishing a subrogation claim for an individual insured, or for their insureds in the aggregate? How might they prove the amount of their claims? And, if they can prove both a claim and its amount, does it even make sense to pursue subrogation? Recall that such a claim will be unsecured and, under federal law, may be subordinated to the claim of an associated creditor.[17]

And, finally, there are policy allocation issues to contend with. Given that the epidemic has been decades in the making and will likely take decades to resolve, how many insurance periods might be at issue? How many insureds? And are other insurers involved? While the answer to the first question will depend on the particular facts of each case, many opioid-related cases will involve multiple insureds and insurers, increasing the complexity and cost of litigation considerably.

And of course, the coverage issues are complex and far reaching. How far will the intentional act exclusion stretch in cases dealing with opioids? Will exclusions dealing with criminal acts apply? Does the conduct even fall into that of an occurrence? These issues are no longer hypothetical and a plan to deal with them is needed.

Even in individual cases insurers will need to plan. Where abuse of prescription drugs was once upon a time viewed as a factor which would mitigate damages, addiction issues are now popping up as a possible aggregator. Insurers need to consider the need for experts in the areas of addiction, consider the possibility that life care issues concerning drug dependency may become part of the damages in individual cases and consider that defense counsel may need training on how to respond to such concerns.

Another headline-grabbing topic, cannabis, presents a different—though not entirely unrelated—a set of planning issues for insurers. Now legal for medicinal use in 33 states and for recreational use in 11 states, the District of Columbia, Guam, and Puerto Rico,[18] marijuana is cropping up in new ways in civil litigation and insurance claims.[19] In light of the steady progress of legalization, insurers should be wondering in particular about their insureds’ workplace drug policies and the potential for cannabis-related damages.

While these areas present very much open questions, there are compelling clues from around the country. New York City, for example, now prohibits employers under certain circumstances from requiring job applicants to take marijuana drug tests.[20] Nevada generally limits employers from denying applicants employment based on a positive test for marijuana.[21] In Florida, the plaintiff in a car-accident suit claimed—and was awarded—more than $25,000 in medical marijuana costs as part of her damages.[22] And in Maryland, a public school employee who abused legally prescribed marijuana was permitted to retain his position, despite the fact that his continued employment put the school’s federal funding at risk.

The present uncertainty about how various uses and abuses of cannabis will play out in court will be resolved in time by how, as a society, we ultimately regard the drug: More like alcohol, as a recreational activity to be indulged in moderation? Or more like opioids, as a medicine to be carefully doled out under certain circumstances? In the interim, insurers face tough questions with respect to the sheer variety of claims that might arise in the context of cannabis legalization and the damages that those claims might entail in litigation.

There are so many questions with so few answers at this point in time. But as Lewis Carroll noted, “if you don’t know where you are going, any road will get you there.” So insurers in particular need to determine what roads to take by planning–planning how to deal with the pending bankruptcies, planning how to deal with the possible “who is next” defendant scenarios, and determining how to deal with issues relating to cannabis both as a work place issue, a brand issue and as a coverage concern. As noted by Benjamin Franklin, “if you fail to plan, you are planning to fail.” Insures should not plan to fail.

[1] NIH/NIDA, Opioid Overdose Crisis (Jan. 2019), https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis#one (citing CDC/NCHS, National Vital Statistics System, Mortality (2018), https://wonder.cdc.gov).

[2] James G. Hodge, Jr., et al., From Opioids to Marijuana: Out of the Tunnel and into the Fog, 67 U. Kan. L. Rev. 879, 882 (2019).

[3] CDC, 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes – United States, 6 (2018), https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillance-report.pdf.

[4] NIH/Nat’l Library of Medicine, Opioid Addiction (Oct. 15, 2019), https://ghr.nlm.nih.gov/condition/opioid-addiction; Anuj Shah, et al., Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use – United States, 2006–2015, CDC Morbidity and Mortality Weekly Report (Mar. 17, 2017), https://www.cdc.gov/mmwr/volumes/66/wr/mm6610a1.htm.

[5] NIH/NIDA, Addressing the Opioid Crisis Means Confronting Socioeconomic Disparities (Oct. 25, 2017), https://www.drugabuse.gov/about-nida/noras-blog/2017/10/addressing-opioid-crisis-means-confronting-socioeconomic-disparities; Laxmaiah Manchikanti, et al., Opioids in Chronic Noncancer Pain: Have We Reached a Boiling Point Pet? Pain Physician (2014), https://pdfs.semanticscholar.org/2b05/06722c741dd71660b7779cd4df52b67fc2e0.pdf.

[6] NIH/NIDA, Dramatic Increases in Maternal Opioid Use and Neonatal Abstinence Syndrome (Jan. 2019), https://www.drugabuse.gov/related-topics/trends-statistics/infographics/dramatic-increases-in-maternal-opioid-use-neonatal-abstinence-syndrome.

[7] NIH/NIDA, supra note 1.

[8] Altarum, Economic Toll of Opioid Crisis in U.S. Exceeded $1 Trillion Since 2001 (Feb. 13, 2018), https://altarum.org/news/economic-toll-opioid-crisis-us-exceeded-1-trillion-2001.

[9] NIH/NIDA, supra note 1; Nicholas Hagemeier, Introduction to the Opioid Epidemic: The Economic Burden on the Healthcare System and Impact on Quality of Life (May 11, 2018), https://www.ajmc.com/journals/supplement/2018/combating-opioid-epidemic/intro-opioid-epidemic-economic-burden-on-healthcare-system-impact-quality-of-life.

[10] Manchikanti, supra note 5.

[11] In re Nat’l Prescription Opiate Litig., No. 1:17-MD-2804 (N.D. Ohio 2019).

[12] Id.

[13] See, for example, Pls.’ Am. Compl. At 3, Cherokee Nation v. Purdue Pharma et al., No. 1:18-MD-46325 (N.D. Ohio Aug. 12, 2019), consolidated under In re Nat’l Prescription Opiate Litig., No. 1:17-MD-2804 (N.D. Ohio 2019).

[14] Sara Randazzo, New Front on Opioid Litigation: Suits Over Rising Premiums, Wall Street Journal (May 2, 2018), https://www.wsj.com/articles/new-front-on-opioid-litigation-suits-over-rising-premiums-1525279402.

[15] Berkeley Lovelace, Jr., OxyContin Maker Purdue Pharma Files for Bankruptcy Protection, CNBC (Sep. 15, 2019), https://www.cnbc.com/2019/09/16/oxycontin-maker-purdue-pharma-files-for-bankruptcy-protection.html.

[16] See Paul Carrington, Asbestos Lessons: The Consequences of Asbestos Litigation, 26 Rev. Litig. 583 (2007), https://scholarship.law.duke.edu/cgi/viewcontent.cgi?article=2343&context=faculty_scholarship.

[17] See 11 U.S.C. 509(c).

[18] Governing, State Marijuana Laws in 2019 Map (Jun. 25, 2019), https://www.governing.com/gov-data/safety-justice/state-marijuana-laws-map-medical-recreational.html.

[19] See Teresa Beck & Jay Majitov, The Blame Game: Cannabis Edition, CLM Magazine (Sep. 2019), http://online.pubhtml5.com/adfn/pwaa/#p=38.

[20] Dan Hyman, When the Law Says Using Marijuana Is O.K., but the Boss Disagrees, New York Times (Jul. 19, 2019), https://www.nytimes.com/2019/07/19/business/marijuana-employer-drug-tests.html.

[21] Id.

[22] Beck, supra note 19.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Pessin Katz Law, P.A. | Attorney Advertising

Written by:

Pessin Katz Law, P.A.

Pessin Katz Law, P.A. on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at www.jdsupra.com) (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at privacy@jdsupra.com.

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to privacy@jdsupra.com. We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to privacy@jdsupra.com.

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at: privacy@jdsupra.com.

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at www.jdsupra.com) (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit legal.hubspot.com/privacy-policy.
  • New Relic - For more information on New Relic cookies, please visit www.newrelic.com/privacy.
  • Google Analytics - For more information on Google Analytics cookies, visit www.google.com/policies. To opt-out of being tracked by Google Analytics across all websites visit http://tools.google.com/dlpage/gaoptout. This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit http://www.aboutcookies.org which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at: privacy@jdsupra.com.

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.